Comparison results
Results: Differences Similar | ✘Hemorrhagic vasculitis | ✘Thrombocytopathy | |||||||
Related research | Analogs | Analogs | |||||||
| |||||||||
Distinctive symptoms | |||||||||
Register, to see more distinctive signs of diseases and studies | 49% | — | |||||||
Register, to see more distinctive signs of diseases and studies | — | 48% | |||||||
skin spots | 38% | — | |||||||
paraproteinemic hemoblastoses | — | 34% | |||||||
skin problems | 33% | — | |||||||
thrombocytopenia | — | 34% | |||||||
petechiae | 51% | 18% | |||||||
paraproteinemia | — | 29% | |||||||
red rash | 47% | 15% | |||||||
nosebleed in the morning | — | 28% | |||||||
rheumatism | 30% | — | |||||||
petechiae on the legs | — | 28% | |||||||
consequences of suppression | 29% | — | |||||||
bruises on the legs | — | 27% | |||||||
allergic vasculitis | 28% | — | |||||||
blood diseases | — | 27% | |||||||
small-point rash | 46% | 16% | |||||||
nosebleed | — | 26% | |||||||
inflammation | 22% | — | |||||||
willebrand 's disease | — | 24% | |||||||
acute glomerulonephritis | 15% | — | |||||||
vitamin b12 boost2 | — | 23% | |||||||
erythrocytic cylindruria | 15% | — | |||||||
parasitic liver diseases | — | 22% | |||||||
need for chocolate | 15% | — | |||||||
b12-deficiency anemia | — | 21% | |||||||
joint pain wandering | 14% | — | |||||||
bleeding | — | 21% | |||||||
rash on the buttocks | 13% | — | |||||||
blood loss | — | 21% | |||||||
papular urticaria | 13% | — | |||||||
dysfunctional uterine bleeding | — | 20% | |||||||
nephrotic syndrome | 13% | — | |||||||
vitamin c increased | — | 20% | |||||||
cylinders | 13% | — | |||||||
red rash on the legs | — | 20% | |||||||
prurigo | 13% | — | |||||||
poisoning addison | — | 20% | |||||||
pain in large joints | 13% | — | |||||||
vitamin b12 reduction2 | — | 19% | |||||||
chronic glomerulonephritis | 12% | — | |||||||
anemia | — | 19% | |||||||
chronic kidney disease | 12% | — | |||||||
big nose | — | 19% | |||||||
rashes symmetrical | 12% | — | |||||||
changes in the blood | — | 19% | |||||||
reaction to manta rays | 12% | — | |||||||
rash on the nose | — | 19% | |||||||
obesity on the stomach | 12% | — | |||||||
red legs | — | 18% | |||||||
rashes bubbles | 12% | — | |||||||
posthemorrhagic anemia | — | 18% | |||||||
glomerulonephritis | 12% | — | |||||||
bleeding uterine | — | 18% | |||||||
wandering pains | 12% | — | |||||||
liver cancer | — | 18% | |||||||
joint diseases | 12% | — | |||||||
cancer | — | 18% | |||||||
fat deposits | 11% | — | |||||||
blood dark | — | 18% | |||||||
blood in feces | 11% | — | |||||||
rash in the mouth | — | 18% | |||||||
hypercoagulation syndrome | 11% | — | |||||||
vitamin c reduced | — | 18% | |||||||
fecal vomiting | 11% | — | |||||||
scurvy | — | 18% | |||||||
decrease in gamma globulins | 11% | — | |||||||
posttransfusion complications | — | 18% | |||||||
brown pigmentation after rashes | 10% | — | |||||||
bruise | — | 17% | |||||||
brown spots on the skin | 10% | — | |||||||
mucous hyperemia | — | 17% | |||||||
vaccination | 10% | — | |||||||
worse at 12 o'clock | — | 17% | |||||||
intestinal bleeding | 10% | — | |||||||
oncology | — | 17% | |||||||
inflammation | 10% | — | |||||||
rashes on his legs | — | 17% | |||||||
refuses to help | 10% | — | |||||||
lymphocytic | — | 17% | |||||||
vomiting blood | 10% | — | |||||||
leukemia | — | 17% | |||||||
pain in the intestines | 9% | — | |||||||
liver dysfunction | — | 16% | |||||||
acute condition | 9% | — | |||||||
serum sickness | — | 16% | |||||||
peptic ulcer | 9% | — | |||||||
the skin is dark | — | 16% | |||||||
papules | 9% | — | |||||||
cirrhosis of the liver | — | 16% | |||||||
does not feel pain | 9% | — | |||||||
helminths | — | 16% | |||||||
painful appearance | 9% | — | |||||||
protein with increased | — | 15% | |||||||
nephropathy | 9% | — | |||||||
protein c deficiency | — | 15% | |||||||
constant pain | 9% | — | |||||||
bleeding | 14% | 29% | |||||||
weakening of immunity | 9% | — | |||||||
blue skin | — | 15% | |||||||
proteinuria | 9% | — | |||||||
effects of puberty | — | 15% | |||||||
joint pain | 9% | — | |||||||
beriberi | — | 15% | |||||||
subacute condition | 8% | — | |||||||
family man | — | 14% | |||||||
immunodeficiency | 8% | — | |||||||
benign neoplasms | — | 14% | |||||||
skin sensations | 8% | — | |||||||
dyspnea | — | 14% | |||||||
heart dysfunction | 8% | — | |||||||
female pelvic organs | — | 14% | |||||||
up circulatory disorders | 8% | — | |||||||
liver problems | — | 13% | |||||||
vomiting | 8% | — | |||||||
hemorrhagic diathesis | 13% | 25% | |||||||
necrosis | 8% | — | |||||||
blood paraproteins are lowered | — | 11% | |||||||
consequences of infection | 8% | — | |||||||
rash on the limbs | 11% | 18% | |||||||
skin condition | 8% | — | |||||||
hemorrhagic syndrome | 12% | 19% | |||||||
childhood diseases | 7% | — | |||||||
rash on the torso | 11% | 18% | |||||||
uremia | 11% | 18% | |||||||
protein reduced | 9% | 15% | |||||||
hematuria | 8% | 14% | |||||||
hemorrhages on the skin | 14% | 16% | |||||||
injury | 10% | 12% | |||||||
dic syndrome | 15% | 17% | |||||||
consequences of injuries | 12% | 13% |
Instructions
Video
|